- Home
- PULM vs UONEK Comparison
PULM vs UONEK Comparison
Compare PULM & UONEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PULM
- UONEK
- Stock Information
- Founded
- PULM 2003
- UONEK 1980
- Country
- PULM United States
- UONEK United States
- Employees
- PULM N/A
- UONEK N/A
- Industry
- PULM Biotechnology: Pharmaceutical Preparations
- UONEK Broadcasting
- Sector
- PULM Health Care
- UONEK Consumer Discretionary
- Exchange
- PULM Nasdaq
- UONEK Nasdaq
- Market Cap
- PULM 33.2M
- UONEK 28.1M
- IPO Year
- PULM N/A
- UONEK N/A
- Fundamental
- Price
- PULM $5.62
- UONEK $0.65
- Analyst Decision
- PULM
- UONEK
- Analyst Count
- PULM 0
- UONEK 0
- Target Price
- PULM N/A
- UONEK N/A
- AVG Volume (30 Days)
- PULM 11.2K
- UONEK 297.6K
- Earning Date
- PULM 08-12-2025
- UONEK 08-19-2025
- Dividend Yield
- PULM N/A
- UONEK N/A
- EPS Growth
- PULM N/A
- UONEK N/A
- EPS
- PULM N/A
- UONEK N/A
- Revenue
- PULM $1,921,000.00
- UONEK $437,499,000.00
- Revenue This Year
- PULM N/A
- UONEK N/A
- Revenue Next Year
- PULM $134.88
- UONEK N/A
- P/E Ratio
- PULM N/A
- UONEK N/A
- Revenue Growth
- PULM N/A
- UONEK N/A
- 52 Week Low
- PULM $1.78
- UONEK $0.44
- 52 Week High
- PULM $10.40
- UONEK $1.57
- Technical
- Relative Strength Index (RSI)
- PULM 32.49
- UONEK 49.82
- Support Level
- PULM $5.60
- UONEK $0.57
- Resistance Level
- PULM $6.15
- UONEK $0.69
- Average True Range (ATR)
- PULM 0.28
- UONEK 0.16
- MACD
- PULM -0.05
- UONEK -0.00
- Stochastic Oscillator
- PULM 1.63
- UONEK 13.22
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
About UONEK Urban One Inc. Class D
Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.